feed,title,long_url,short_url
Benzinga,Astellas - Seagen's PADCEV Wins Full FDA Approval And Expanded Label In Tough-To-Treat Urothelial Cancer,https://benzinga.com/general/biotech/21/07/21932502/astellas-seagens-padcev-wins-full-fda-approval-and-expanded-label-in-tough-to-treat-urothelial-ca,https://j.mp/3xG2FDS
